The disc is a visceolastic one-piece, next generation total disc replacement featuring a polymer core, designed to restore function of the spine and reduce pain and disability. The company is able to commercially distribute the disc in Europe and will purse the FDA IDE approval in the United States in the future.
More Articles on Orthopedic Devices:
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
Orthofix Completes Sale of Sports Medicine Business
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.